High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Kashuba, Vladimir I ^a,b   Pavlova, Tatiana V ^a,c   Grigorieva, Elvira V ^a,d   Kutsenko, Alexey ^a,c   Yenamandra, Surya Pavan ^a   Li, Jingfeng ^a   Wang, Fuli ^a   Protopopov, Alexei I ^a   Zabarovska, Veronica I ^a   Senchenko, Vera ^a,c   Haraldson, Klas ^a   Eshchenko, Tatiana ^a,d   Kobliakova, Julia ^a   Vorontsova, Olga ^a   Kuzmin, Igor ^e,f   Braga, Eleonora ^g   Blinov, Vladimir M ^h   Kisselev, Lev L ^c   Zeng, Yi Xin ⁱ   Ernberg, Ingemar ^a   Lerman, Michael I ^e   Klein, George ^a   Zabarovsky, Eugene R ^a,c   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^e NATIONAL CANCER INSTITUTE   (United States)

^f SAIC FREDERICK INC   (United States)

^g Russian State Genetics Center   (Russian Federation)

^h STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

ⁱ SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE; BACTERIAL DNA; COMPLEMENTARY DNA; ENZYME; UNCLASSIFIED DRUG; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); APOLIPOPROTEIN B MRNA EDITING ENZYME; CTDSPL PROTEIN, HUMAN; CYTIDINE DEAMINASE; ESCHERICHIA COLI PROTEIN; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GENETICS; CANCER INHIBITION; CARCINOGENESIS; CELL CLONING; CELL PROLIFERATION; CONTROLLED STUDY; ESCHERICHIA COLI; EXON; EXPRESSED SEQUENCE TAG; FEMALE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENE SEQUENCE; GENOME ANALYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTO ONCOGENE; RAS ASSOCIATION DOMAIN FAMILY 1A GENE; SOMATIC HYPERMUTATION; TRANSGENE; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE RBSP3; ANIMAL; BIOLOGY; CELL CLONE; CELL LINE; FOUNDER EFFECT; GENETICS; GENOME; HEMATOPOIESIS; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; MOUSE MUTANT; MUTATION; NEOPLASM; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; COMPUTATIONAL BIOLOGY; CYTIDINE DEAMINASE; DNA, BACTERIAL; DNA, COMPLEMENTARY; ESCHERICHIA COLI PROTEINS; EXPRESSED SEQUENCE TAGS; FOUNDER EFFECT; GENOME; HEMATOPOIESIS; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, SCID; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 66749104393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005231     Document Type: Article

References (36)

1. Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, et al. (2000) Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 19: 1392-1399.
2. Braga E, Senchenko V, Bazov I, Loginov W, Liu J, Ermilova V, et al. (2002) Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR. Int J Cancer 100: 534-541.
3. Li J, Protopopov A, Wang F, Senchenko V, Petushkov V, Vorontsova O, et al. (2002) NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A 99: 10724-10729.
4. Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, Seryogin Y, et al. (2003) Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 22: 2984-2992.
5. Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, et al. (2004) Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23: 5719-5728.
6. Zabarovsky ER, Lerman MI, Minna JD (2002) Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21: 6915-6935.
7. Imreh S, Klein G, Zabarovsky ER (2003) Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38: 307-321.
8. Dammann R, Schagdarsurengin U, Strunnikova M, Rastetter M, Seidel C, Liu L, et al. (2003) Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol 18: 665-677.
9. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA (2002) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318.
10. Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukova A, et al. (2004) RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A 101: 4906-4911.
11. Buermeyer AB, Deschenes SM, Baker SM, Liskay RM (1999) Mammalian DNA mismatch repair. Annu Rev Genet 33: 533-564.
12. Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, et al. (2003) An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 63: 404-412.
13. Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, et al. (2004) Functional characterization of the candidate tumor suppressor gene NPRL2/ G21 located in 3p21.3C. Cancer Res 64: 6438-6443.
14. Spandidos DA (1986) A unified theory for the development of cancer. Biosci Rep 6(8): 691-708.
15. Bishop JM (1987) The molecular genetics of cancer. Science 235(4786): 305-311.
16. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, et al. (2001) The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A 98: 7504-7509.
17. Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, et al. (2002) The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 62: 3498-3502.
18. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319.
19. Lerman MI, Minna JD (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60: 6116-6133.
20. Muto T, Muramatsu M, Taniwaki M, Kinoshita K, Honjo T (2000) Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68: 85-88.
21. Beale RC, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS (2004) Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol 337: 585-596.
22. Conticello SG, Thomas CJ, Petersen-Mahrt S, Neuberger MS (2005) Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 22: 367-77.
23. Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, et al. (2004b) Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 23: 5941-5949.
24. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197: 1173-1181.
25. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, et al. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412: 341-346.
26. Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, Klein G, et al. (2002) Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med 4: 397-406.
27. Li J, Protopopov AI, Gizatullin RZ, Kiss C, Kashuba VI, Winberg G, et al. (1999) Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene. FEBS Lett 451: 289-294.
28. Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH, et al. (2005) High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 4: 1116-1122.
29. Gearhart PJ, Wood RD (2001) Emerging links between hypermutation of antibody genes and DNA polymerases. Nat Rev Immunol 1: 187-192.
30. Rogozin IB, Pavlov YI, Bebenek K, Matsuda T, Kunkel TA (2001) Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat Immunol 2: 530-536.
31. Zeng X, Winter DB, Kasmer C, Kraemer KH, Lehmann AR, Gearhart PJ (2001) DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol 2: 537-541.
32. Strauss BS (2000) Role in tumorigenesis of silent mutations in the TP53 gene. Mutation Research 457: 93-104.
33. Brulliard M, Lorphelin D, Collignon O, Lorphelin W, Thouvenot B, Gothie E, et al. (2007) Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis. Proc Natl Acad Sci U S A 104: 7522-7527.
34. Wang J, Gonzalez KD, Scaringe WA, Tsai K, Liu N, Gu D, et al. (2007) Evidence for mutation showers. Proc Natl Acad Sci U S A 104: 8403-8408.
35. Yang Y, Sterling J, Storici F, Resnick MA, Gordenin DA (2008) Hypermutability of damaged single-strand DNA formed at double-strand breaks and uncapped telomeres in Yeast Saccharomyces cerevisiae. PLoS Genet 4(11): e1000264.
36. Chumakov IM, Zabarovsky ER, Prassolov VS, Mett VL, Kisselev LL (1982) Human nucleotide sequences related to the transforming gene of a murine sarcoma virus: studies with cloned viral and cellular DNAs. Gene 17: 19-26.